This is why GLP-1 is valuable when treating type 2 diabetes
Other lipid-lowering therapies include: Ezetimibe : Reduces LDL cholesterol by approximately 1520% by inhibiting intestinal cholesterol absorption Bempedoic acid : Lowers LDL cholesterol by 15-25%, often used with ezetimibe when statins are contraindicated or not tolerated PCSK9 inhibitors : Achieve dramatic LDL reductions of 5060%, reserved for patients with very high cardiovascular risk or familial hypercholesterolaemia Fibrates : Primarily target triglycerides (reductions of 3050%) with modest effects on LDL cholesterol Icosapent ethyl : A prescription-grade omega-3 fatty acid that may be used in selected high-risk patients
Regular Follow-Ups: Routine check-ins and lab testing ensure safety, balance, and optimal dosing
Using a flow cytometry-based assay for intracellular glutathione, we found that although melatonin increased cellular GSH levels, this effect was lost when cells were co-treated with melatonin and IKE ( Figure 6I )
REGULATION OF CELL DEATH BY mGSH As opposed to apoptosis, necrosis is a morphologically distinct form of cell death responsible for irreversible tissue destruction due to bioenergetic failure and oxidative damage
Understanding how it compares to alternatives helps you choose the right strategy for your situation